The Food and Drug Administration is changing the most common way it approves new low- to moderate-risk medical devices for use in the United States.
Since 1976, manufacturers have been able to pursue an expedited approval process, known as 510(k), if they could prove new products were substantially equivalent to devices, known as predicates, that had previously earned FDA approval.